These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9469321)

  • 21. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival in epithelial ovarian cancer patients with prior breast cancer.
    McGuire V; Whittemore AS; Norris R; Oakley-Girvan I
    Am J Epidemiol; 2000 Sep; 152(6):528-32. PubMed ID: 10997542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
    Aida H; Takakuwa K; Nagata H; Tsuneki I; Takano M; Tsuji S; Takahashi T; Sonoda T; Hatae M; Takahashi K; Hasegawa K; Mizunuma H; Toyoda N; Kamata H; Torii Y; Saito N; Tanaka K; Yakushiji M; Araki T; Tanaka K
    Clin Cancer Res; 1998 Jan; 4(1):235-40. PubMed ID: 9516977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
    Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA
    Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of BRCA1 negative ovarian cancer patients based on family history.
    Chu CS; Morgan MA; Randall TC; Bandera CA; Rubin SC
    Gynecol Oncol; 2001 Oct; 83(1):109-14. PubMed ID: 11585421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO; Mahoney NM; Miller DS; Coleman RL; Muller CY; Euhus DM; Tomlinson GE
    Gynecol Oncol; 2001 Nov; 83(2):383-7. PubMed ID: 11606101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
    Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
    Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.
    Huzarski T; Byrski T; Gronwald J; Górski B; Domagala P; Cybulski C; Oszurek O; Szwiec M; Gugala K; Stawicka M; Morawiec Z; Mierzwa T; Janiszewska H; Kilar E; Marczyk E; Kozak-Klonowska B; Siolek M; Surdyka D; Wisniowski R; Posmyk M; Sun P; Lubinski J; Narod SA
    J Clin Oncol; 2013 Sep; 31(26):3191-6. PubMed ID: 23940229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
    Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J
    Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.
    Randall TC; Bell KA; Rebane BA; Rubin SC; Boyd J
    Gynecol Oncol; 1998 Sep; 70(3):432-4. PubMed ID: 9790802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
    Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
    Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio RA; Tsukada Y; Ponder BA; Piver MS
    Hum Pathol; 2000 Nov; 31(11):1420-4. PubMed ID: 11112219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Germ-line mutations of the BRCA1 gene in northeastern France].
    Fricker JP; Muller D; Cutuli B; Rodier JF; Janser JC; Jung GM; Mors R; Petit T; Haegele P; Abecassis J
    Bull Cancer; 2000 Oct; 87(10):739-44. PubMed ID: 11084537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern France.
    Peyrat JP; Vennin P; Hornez L; Fournier J; Adenis C; Bonneterre J
    Eur J Cancer Prev; 1998 Feb; 7 Suppl 1():S7-12. PubMed ID: 10866029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations.
    Garcia-Patiño E; Gomendio B; Provencio M; Silva JM; Garcia JM; España P; Bonilla F
    J Clin Oncol; 1998 Jan; 16(1):115-20. PubMed ID: 9440731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
    Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM
    Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 mutations in German breast-cancer families.
    Jandrig B; Grade K; Seitz S; Waindzoch B; Müller M; Bender E; Nothnagel A; Rohde K; Schlag PM; Kath R; Höffken K; Scherneck S
    Int J Cancer; 1996 Oct; 68(2):188-92. PubMed ID: 8900426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.